Guardian Wealth Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Guardian Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$283.23 - $323.1 $566 - $646	2 New	2 $0
Q3 2022 Nov 09, 2022	BUY	$273.83 - $305.53 $81,327 - $90,742	297 New	297 $86,000
Q2 2021 Jul 28, 2021	SELL	$187.49 - $221.1 $212,613 - $250,727	-1,134 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$207.02 - $241.31 $234,760 - $273,645	1,134 New	1,134 $243,000

1,707

226M

1.2M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Guardian Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Guardian Wealth Advisors, LLC with notifications on news.